Chemoprevention of urinary bladder carcinogenesis by flavokawain A
黄素卡因 A 对膀胱癌的化学预防
基本信息
- 批准号:8204560
- 负责人:
- 金额:$ 31.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-10 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAgeAnimal ModelApoptosisApoptoticAreaBAX geneBCL1 OncogeneBCL2 geneBCL2L11 geneBIRC4 geneBindingBladderBladder NeoplasmBody WeightCYP1B1 geneCancer PatientCarcinogensCarcinoma in SituCdc25C proteinCell Culture TechniquesCell CycleCell Cycle ArrestCell Cycle RegulationCell LineCellsCessation of lifeChalconeChalconesChemical StructureChemopreventionChemopreventive AgentClinicalClinical TrialsConsumptionDNADNA BindingDataDevelopmentDiagnosisDietDiseaseDown-RegulationEnzymesEpidemiologic StudiesEpithelial CellsEpitheliumEventExhibitsExposure toFamilyFamily memberFoodFrequenciesGoalsHigh PrevalenceHumanImmunohistochemistryImmunoprecipitationIn VitroIncidenceInduction of ApoptosisKavaMCL1 geneMDM2 geneMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of urinary bladderMediatingMetabolismMethodsMicroarray AnalysisMitochondriaModelingMolecularMorphologyMusNatureNew AgentsNitrosaminesNormal CellPacific IslandsPapillaryPapillary CarcinomaPapillary NeoplasmPapillary Transitional Cell CarcinomaPathway interactionsPatientsPhasePhosphorylationPhosphotransferasesPilot ProjectsPlant RootsPlantsPlayPopulationPost-Translational Protein ProcessingPremalignantPrimary PreventionPrincipal InvestigatorProdrugsProteinsPublic HealthRNA InterferenceRecurrenceReportingRisk FactorsRoleS PhaseSKP2 geneSecondary PreventionSmokerSolidStagingStreamTestingTimeTobacco smokingToxic effectTransgenic MiceTransgenic ModelTransgenic OrganismsTransitional Cell CarcinomaTumor BurdenTumor WeightsUp-RegulationUreterUrineUrotheliumWeightWestern BlottingXenograft Modelbasebeta Tubulinbladder cancer preventioncancer cellcancer chemopreventioncancer recurrencecarcinogenesischemotherapeutic agentcigarette smokingcostcyclin-dependent kinase inhibitor 1Bdietary supplementsfeedinghuman PLK1 proteinin vivoindexinginnovationinterestkavainknock-downmouse modelmutantnoveloncoprotein p21overexpressionpreventprogramssurvivintumortumor growthtumor progressionvector
项目摘要
DESCRIPTION (provided by applicant):
Bladder cancer represents a major public health burden. The cost per bladder cancer patient from diagnosis to death is the highest among all cancers ($96,000 to $187, 000 per patient in the US). Our long-term goal is to develop new chemopreventive agents to reduce the burden of bladder cancer. Because exposure to carcinogens is the major risk factor for bladder cancer and many potentially protective compounds contained in plant-derived food are concentrated in the urine, it is plausible that bioactive agents in plants may play a role in bladder cancer chemoprevention. Flavokawain A is the predominant chalcone identified from kava root extract. The promise of flavokawain A is based on the following data : 1) an epidemiological study reported that high kava consumption correlated with lower incidences of cancers despite the presence of many smokers in the populations of the South Pacific Islands; 2) In vitro cell culture studies showed that flavokawains but not kavalactones in kava extracts exhibited strong antiproliferative and apoptotic effects on human bladder cancer cells characterized as low- and high- grades; 3) Flavokawain A inhibited tumor growth in xenograft models of superficial and invasive bladder cancer without any noticeable side effects; and 4) The chemical structure of flavokawain A, similar to some other chalcones, leads us to predict that it would cause no direct damage to DNA, bind to beta-tubulin, and induce phase II enzymes to protect against carcinogenesis. We hypothesize flavokawain A has chemopreventive effects on bladder epithelium via enhancing cell cycle regulation and increasing the sensitivity of apoptotic mechanisms. Three mouse models will be used to test this hypothesis: a carcinogen [4-hydroxybutyl (butyl) nitrosamine (OH-BBN)]-induced carcinogenesis model in mice bladders, and two spontaneous mouse bladder transgenic carcinogenesis models, each of which will address distinct issues. The OH-BBN model in mice will be used to examine flavokawain A's utility in primary prevention; for preventing the first occurrence of bladder cancer in those with risk factors such as cigarette smoking and industrial exposures. The transgenic models each induce a separate precursor state to advanced bladder cancer: either papillary tumors or carcinoma in situ, as seen in early stages of clinical bladder cancer. Examining flavokawain A in these transgenic models will provide information about its usefulness in secondary prevention, which clinically will address preventing bladder cancer recurrence and progression. Our microarray analysis has identified a few potential transcriptional targets (i.e. BIM, BID, survivin, Plk1, 14-3-3gamma, and SKP-2) for flavokawain A when inducing apoptosis and cell cycle arrests. We will validate these targets by examining their expression in vivo in these tested animal models and by using RNA interference and overexpression vectors to determine their contributions to flavokawain A's action in vitro, as well as by studying the down-stream events of these targets. Together, these studies will provide a firm answer to the promise of flavokawin A as a chemoprventative and/or chemotherapeutic agent.
描述(由申请人提供):
膀胱癌是一个主要的公共卫生负担。膀胱癌患者从诊断到死亡的成本是所有癌症中最高的(美国每位患者96,000至187,000美元)。我们的长期目标是开发新的化学预防剂,以减少膀胱癌的负担。由于暴露于致癌物是膀胱癌的主要危险因素,并且植物源性食品中含有的许多潜在保护化合物集中在尿液中,因此植物中的生物活性剂可能在膀胱癌化学预防中发挥作用。卡瓦黄素A是从卡瓦根提取物中鉴定的主要查耳酮。flavokawain A的前景是基于以下数据:1)一项流行病学研究报告说,尽管南太平洋岛屿的人口中有许多吸烟者,但高卡瓦消费与癌症发病率较低有关;(二)体外细胞培养研究表明,卡瓦提取物中的卡瓦黄素而不是卡瓦内酯对人膀胱癌细胞表现出强烈的抗增殖和凋亡作用,低级和高级; 3)卡瓦胡椒素A在浅表性和浸润性膀胱癌的异种移植模型中抑制肿瘤生长,而没有任何明显的副作用;以及4)卡瓦胡椒素A的化学结构与一些其他查耳酮类似,使我们预测它不会对DNA造成直接损伤,与β-微管蛋白结合,并诱导II相酶以防止致癌。我们推测卡瓦胡椒素A通过增强细胞周期调节和增加凋亡机制的敏感性对膀胱上皮细胞具有化学预防作用。将使用三种小鼠模型来验证这一假设:致癌物[4-羟丁基(丁基)亚硝胺(OH-BBN)]诱导的小鼠膀胱致癌模型,以及两种自发小鼠膀胱转基因致癌模型,每种模型都将解决不同的问题。小鼠中的OH-BBN模型将用于检查黄素卡瓦因A在一级预防中的效用;用于预防具有吸烟和工业暴露等风险因素的人首次发生膀胱癌。转基因模型各自诱导一种单独的晚期膀胱癌前体状态:乳头状肿瘤或原位癌,如在临床膀胱癌的早期阶段所见。在这些转基因模型中检查黄素卡瓦因A将提供关于其在二级预防中的有用性的信息,这将在临床上解决预防膀胱癌复发和进展的问题。我们的微阵列分析已经确定了一些潜在的转录靶点(即BIM,BID,生存素,Plk 1,14-3-3gamma,和SKP-2)的黄素卡瓦菌素A时,诱导细胞凋亡和细胞周期停滞。我们将验证这些目标,通过检查它们在这些测试的动物模型中的体内表达,并通过使用RNA干扰和过表达载体,以确定它们的贡献,在体外的黄素卡瓦菌素A的行动,以及通过研究这些目标的下游事件。总之,这些研究将提供一个坚定的答案,作为一个化学预防和/或化疗剂的flavokawin A的承诺。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular targeted approaches to cancer therapy and prevention using chalcones.
- DOI:10.2174/1568009614666140122160515
- 发表时间:2014
- 期刊:
- 影响因子:3
- 作者:Jandial DD;Blair CA;Zhang S;Krill LS;Zhang YB;Zi X
- 通讯作者:Zi X
Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.
- DOI:10.1021/jm401002r
- 发表时间:2013-11-14
- 期刊:
- 影响因子:7.3
- 作者:Zheng YC;Duan YC;Ma JL;Xu RM;Zi X;Lv WL;Wang MM;Ye XW;Zhu S;Mobley D;Zhu YY;Wang JW;Li JF;Wang ZR;Zhao W;Liu HM
- 通讯作者:Liu HM
When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?
当抗衰老研究符合癌症化学预防时:抗衰老剂可以用一击杀死两只鸟吗?
- DOI:10.1007/s40495-015-0039-5
- 发表时间:2015-12-01
- 期刊:
- 影响因子:0
- 作者:Yokoyama NN;Denmon A;Uchio EM;Jordan M;Mercola D;Zi X
- 通讯作者:Zi X
Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin.
- DOI:10.3390/molecules22030462
- 发表时间:2017-03-14
- 期刊:
- 影响因子:0
- 作者:Jandial DD;Krill LS;Chen L;Wu C;Ke Y;Xie J;Hoang BH;Zi X
- 通讯作者:Zi X
Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice.
- DOI:10.1371/journal.pone.0031213
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Li X;Liu Z;Xu X;Blair CA;Sun Z;Xie J;Lilly MB;Zi X
- 通讯作者:Zi X
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiaolin Zi其他文献
Xiaolin Zi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiaolin Zi', 18)}}的其他基金
CMA-Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Interception of tobacco smoking-related bladder cancer by an epigenetic approach
CMA-暴露于致癌物的退伍军人尿路上皮癌症发生的基本和转化机制:通过表观遗传学方法拦截与吸烟相关的膀胱癌
- 批准号:
10260302 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
A novel targetable mechanism for castration-resistant prostate cancer
去势抵抗性前列腺癌的新型靶向机制
- 批准号:
10513281 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
CMA-Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Interception of tobacco smoking-related bladder cancer by an epigenetic approach
CMA-暴露于致癌物的退伍军人尿路上皮癌症发生的基本和转化机制:通过表观遗传学方法拦截与吸烟相关的膀胱癌
- 批准号:
10647629 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
The NEDD8 pathway mediated Skp2 degradation in chemoprevention by FKA
FKA 化学预防中 NEDD8 通路介导的 Skp2 降解
- 批准号:
9176833 - 财政年份:2016
- 资助金额:
$ 31.02万 - 项目类别:
Rhodiola Rosea Extracts, Salidroside and Bladder Cancer Chemoprevention
红景天提取物、红景天苷和膀胱癌的化学预防
- 批准号:
8114959 - 财政年份:2011
- 资助金额:
$ 31.02万 - 项目类别:
Rhodiola Rosea Extracts, Salidroside and Bladder Cancer Chemoprevention
红景天提取物、红景天苷和膀胱癌的化学预防
- 批准号:
8239511 - 财政年份:2011
- 资助金额:
$ 31.02万 - 项目类别:
Chemoprevention of urinary bladder carcinogenesis by flavokawain A
黄素卡因 A 对膀胱癌的化学预防
- 批准号:
8209757 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
Chemoprevention of urinary bladder carcinogenesis by flavokawain A
黄素卡因 A 对膀胱癌的化学预防
- 批准号:
7538351 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
Lycopene & Docetaxel in Prostate Cancer: An IGF-I Receptor Targeting Approach
番茄红素
- 批准号:
7496103 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
Lycopene & Docetaxel in Prostate Cancer: An IGF-I Receptor Targeting Approach
番茄红素
- 批准号:
7297046 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 31.02万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 31.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 31.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 31.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
Studentship